+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bronchitis Treatment Market - Global Forecast 2025-2030- Product Image
Bronchitis Treatment Market - Global Forecast 2025-2030- Product Image
Sale

Bronchitis Treatment Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011465
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The bronchitis treatment market is progressing through a period of significant transformation, marked by advances in diagnostic precision, therapeutics, and digital care models. Stakeholders in pharmaceuticals, biotechnology, healthcare provision, and supply chain management are responding to evolving patient expectations and global policy shifts.

Market Snapshot: Bronchitis Treatment Market Growth and Trends

The Bronchitis Treatment Market grew from USD 7.16 billion in 2024 to USD 7.66 billion in 2025. With a projected CAGR of 6.78%, the market is expected to reach USD 10.62 billion by 2030. This trajectory is fueled by innovation in personalized care, the adoption of digital health solutions, and integration of value-based models across leading global economies.

Scope & Segmentation

This report delivers granular insights into the current landscape and future outlook for bronchitis treatment. The detailed segmentation captures the breadth and depth of therapy modalities, delivery innovations, consumer demographics, and regional variances.

  • Treatment Types: Herbal supplements, over-the-counter remedies, prescription therapies.
  • Drug Classes: Antibiotics (cephalosporins, macrolides, penicillins, tetracyclines), bronchodilators (anticholinergics, beta agonists), corticosteroids (inhaled, intravenous, oral), expectorants (bromhexine, guaifenesin).
  • Route of Administration: Inhalation, oral, topical applications.
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail pharmacies.
  • End Users: Clinics, homecare settings, hospitals.
  • Age Groups: Adult, geriatric, pediatric populations.
  • Product Forms: Capsule, inhaler, liquid, tablet.
  • Key Regional Markets: Americas (including the United States with a focus on California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (spanning United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Company Coverage: Analysis includes GlaxoSmithKline plc, Novartis AG, AstraZeneca plc, Boehringer Ingelheim International GmbH, Sanofi S.A., Pfizer Inc., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Bayer AG, and Viatris Inc.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Precision diagnostics and biomarker profiling are advancing treatment stratification, moving care away from generic approaches to more individualized protocols.
  • Digital therapeutics, including mobile applications and remote monitoring, are enabling improved adherence, streamlined action plans, and data-driven clinical decisions.
  • Therapeutic innovation is highlighted by targeted biologics, novel inhalation technologies, and ongoing research into the respiratory microbiome for potential new treatments.
  • Value-based care models reward positive health outcomes, requiring close collaboration between payers and providers to optimize cost containment and quality of care.
  • Competitiveness is shaped by strategic mergers, digital health integration, and risk-sharing agreements that directly connect reimbursement to patient-centered metrics.
  • Regional disparities in regulatory frameworks and market access prompt the need for tailored go-to-market strategies based on distinct economic and structural strengths.

Tariff Impact: Navigating the 2025 U.S. Import Duty Adjustments

Recent adjustments to U.S. import tariffs on pharmaceutical ingredients are prompting industry leaders to reassess global sourcing, supplier agreements, and domestic manufacturing strategies. Contract renegotiations and regulatory contingencies are now integral for maintaining supply continuity and pricing stability. Healthcare providers and payers are realigning pathway design and payment structures to address any downstream effects on patient access and therapy choices.

Methodology & Data Sources

Robust market intelligence is generated through primary interviews with clinicians, pharmacists, healthcare administrators, and patient advocates, complemented by thorough secondary research across peer-reviewed journals and regulatory filings. Validation is conducted with an expert advisory panel, ensuring every insight is rigorously referenced and aligned with best-in-class analytical standards.

Why This Report Matters

  • Empowers executives to make informed decisions regarding investment priorities, portfolio strategy, and geographic expansion in the bronchitis treatment market.
  • Identifies actionable opportunities and emerging challenges, such as technology adoption, regulatory evolution, and value-based contracting, relevant to evolving care delivery models.
  • Supports forward-looking planning by contextualizing key trends and competitive shifts across regions and care settings.

Conclusion

This report distills actionable intelligence essential for navigating the evolving bronchitis treatment market. Leverage these insights to strengthen resilience, drive innovation, and optimize outcomes for diverse patient populations.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of telehealth platforms for remote monitoring and management of acute bronchitis symptoms
5.2. Rising adoption of antibiotic stewardship protocols to reduce resistance in bronchitis treatment
5.3. Integration of AI powered diagnostic tools for early differentiation between acute and chronic bronchitis
5.4. Growth of patient preference for natural herbal formulations in managing chronic bronchitis flare ups
5.5. Emergence of inhaled combination therapies targeting mucus clearance and airway inflammation simultaneously
5.6. Development of wearable respiratory monitors enabling continuous assessment of lung function during bronchitis recovery
5.7. Customization of treatment regimens based on individual microbiome analysis to optimize bronchitis outcomes
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bronchitis Treatment Market, by Treatment Type
8.1. Introduction
8.2. Herbal Supplements
8.3. Over The Counter
8.4. Prescription
9. Bronchitis Treatment Market, by Drug Class
9.1. Introduction
9.2. Antibiotics
9.2.1. Cephalosporins
9.2.2. Macrolides
9.2.3. Penicillins
9.2.4. Tetracyclines
9.3. Bronchodilators
9.3.1. Anticholinergics
9.3.2. Beta Agonists
9.4. Corticosteroids
9.4.1. Inhaled
9.4.2. Intravenous
9.4.3. Oral
9.5. Expectorants
9.5.1. Bromhexine
9.5.2. Guaifenesin
10. Bronchitis Treatment Market, by Route Of Administration
10.1. Introduction
10.2. Inhalation
10.3. Oral
10.4. Topical
11. Bronchitis Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Bronchitis Treatment Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Homecare
12.4. Hospitals
13. Bronchitis Treatment Market, by Age Group
13.1. Introduction
13.2. Adult
13.3. Geriatric
13.4. Pediatric
14. Bronchitis Treatment Market, by Product Form
14.1. Introduction
14.2. Capsule
14.3. Inhaler
14.4. Liquid
14.5. Tablet
15. Americas Bronchitis Treatment Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Bronchitis Treatment Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Bronchitis Treatment Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. GlaxoSmithKline plc
18.3.2. Novartis AG
18.3.3. AstraZeneca plc
18.3.4. Boehringer Ingelheim International GmbH
18.3.5. Sanofi S.A.
18.3.6. Pfizer Inc.
18.3.7. Johnson & Johnson
18.3.8. Teva Pharmaceutical Industries Ltd.
18.3.9. Bayer AG
18.3.10. Viatris Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. BRONCHITIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BRONCHITIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BRONCHITIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. BRONCHITIS TREATMENT MARKET: RESEARCHAI
FIGURE 30. BRONCHITIS TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 31. BRONCHITIS TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 32. BRONCHITIS TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BRONCHITIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY HERBAL SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY HERBAL SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY PRESCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY MACROLIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY PENICILLINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY TETRACYCLINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY BETA AGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY BETA AGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY INHALED, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY INHALED, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY BROMHEXINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY BROMHEXINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY GUAIFENESIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY GUAIFENESIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 147. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 148. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 149. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 150. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 151. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 152. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 153. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 154. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 155. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 156. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 157. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2018-2024 (USD MILLION)
TABLE 158. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2025-2030 (USD MILLION)
TABLE 159. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 160. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 161. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 166. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 167. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 168. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 169. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 170. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 171. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 172. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 173. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 174. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 175. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 176. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 177. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 178. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 179. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2018-2024 (USD MILLION)
TABLE 180. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2025-2030 (USD MILLION)
TABLE 181. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 182. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 183. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 188. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 189. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 190. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 281. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 282. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 283. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 284. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 285. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 286. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 287. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 288. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 289. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 290. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 291. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2018-2024 (USD MILLION)
TABLE 292. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2025-2030 (USD MILLION)
TABLE 293. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 294. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 295. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 300. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 301. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 302. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 303. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 304. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 305. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 306. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 307. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 308. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 309. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 310. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 311. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 312. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 313. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2018-2024 (USD MILLION)
TABLE 314. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY EXPECTORANTS, 2025-2030 (USD MILLION)
TABLE 315. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 316. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 317. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 322. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 323. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 324. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 325. RUSSIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 326. RUSSIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 327. RUSSIA BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 328. RUSSIA BRONCHITIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 329. RUSSIA BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 330. RUSSIA BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 331. RUSSIA BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2018-2024 (USD MILLION)
TABLE 332. RUSSIA BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATORS, 2025-2030 (USD MILLION)
TABLE 333. RUSSIA BRONCHITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 3

Samples

Loading
LOADING...

Companies Mentioned

  • GlaxoSmithKline plc
  • Novartis AG
  • AstraZeneca plc
  • Boehringer Ingelheim International GmbH
  • Sanofi S.A.
  • Pfizer Inc.
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 7.66 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.62 Billion
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Bronchitis Drugs Market - Global Forecast 2025-2030 - Product Image

Bronchitis Drugs Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Bronchodilators: Market Share, and Growth Analysis by Product Type (Short-Acting Beta Agonists, Long-Acting Beta Agonists, Anticholinergics, Methylxanthines), Application, End User, Technology - Product Image

Bronchodilators: Market Share, and Growth Analysis by Product Type (Short-Acting Beta Agonists, Long-Acting Beta Agonists, Anticholinergics, Methylxanthines), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Bronchodilators - Global Strategic Business Report - Product Image

Bronchodilators - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease Treatment Market - Global Forecast 2025-2030 - Product Image

Chronic Obstructive Pulmonary Disease Treatment Market - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
COPD and Asthma Therapeutics Market Size, Share & Trends Analysis Report by Drug Class (Anti-Inflammatory, Bronchodilators), Device/Product (Inhalers), Technology/Software, Indication, Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Image

COPD and Asthma Therapeutics Market Size, Share & Trends Analysis Report by Drug Class (Anti-Inflammatory, Bronchodilators), Device/Product (Inhalers), Technology/Software, Indication, Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.